Clinical Characteristics, Pharmacotherapy and Healthcare Resource Use Among Patients With Fibromyalgia Newly Prescribed Gabapentin or Pregabalin

Pain Practice - United Kingdom
doi 10.1111/j.1533-2500.2009.00292.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Real-World Treatment of Post-Herpetic Neuralgia With Gabapentin or Pregabalin

Clinical Drug Investigation
MedicinePharmacology
2012English

Pcv111 - Clinical Characteristics and Treatment Patterns Among Patients With Venous Thromboembolism Prescribed Anticoagulants in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Overall Survival, Costs, and Healthcare Resource Use by Line of Therapy in Medicare Patients With Newly Diagnosed Metastatic Urothelial Carcinoma

Journal of Medical Economics
Health Policy
2019English

PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Clinical Utility, Safety, and Efficacy of Pregabalin in the Treatment of Fibromyalgia

Drug, Healthcare and Patient Safety
Health PolicyPharmacology
2016English

Healthcare Services Use Among Dental Patients

ARS Medica Tomitana
BiochemistryMedicineGeneticsMolecular Biology
2019English

Treatment Patterns and Healthcare Resource Utilization Among Patients With Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2020English

Gabapentin and Pregabalin: Do the Benefits Outweigh the Harms?

Journal of the Royal College of Physicians of Edinburgh, The
MedicineEducationHistory
2017English

Pdb94 - Initial Antidiabetic Pharmacotherapy Prescribed to Patients With Newly Diagnosed Type-2 Diabetes in a Commercial Health Plan in the United Stated

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy